Company intelligence / Profile preview

Anthem Capital Management

Baltimore, Maryland, United States

Ownership: Private
Development stage: Other

Overview

Anthem Capital Management was a venture capital firm based in Baltimore, Maryland, that specialized in early-stage investments in the life sciences, healthcare, and technology sectors. Founded in 1994, the firm primarily targeted emerging growth companies within the Mid-Atlantic region of the United States. Its portfolio featured several notable biotechnology and medical device companies, including GlycoMimetics and Nucleonics. The firm is currently inactive, having liquidated its investment funds and ceased new investment activity.

Industry: Investors

Beyond the preview

Go deeper on Anthem Capital Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anthem Capital Management.

Explore the full profile